What is considered the primary mechanism of action for alkylating agents used in chemotherapy?

What is considered the primary mechanism of action for alkylating agents used in chemotherapy?

• A. They inhibit protein synthesis
• B. They damage DNA and prevent cellular replication
• C. They promote apoptosis in cancer cells
• D. They alter the cancer cell's metabolism

Answer: (B)

Alkylating agents are a class of chemotherapy drugs that primarily act by damaging the DNA of cancer cells. Their mechanism involves the addition of alkyl groups to the DNA structure, which can lead to a variety of DNA lesions, including cross-links between DNA strands. This damage disrupts the normal process of DNA replication and transcription, ultimately preventing cancer cells from dividing and proliferating. By interfering with these critical processes, alkylating agents induce cellular stress responses that may lead to cell cycle arrest or apoptosis. The targeted effect on the DNA directly ties into the agents' ability to halt the growth of tumors, making this mechanism a foundational aspect of their use in cancer treatment. The other options, while they may represent different mechanisms associated with other types of chemotherapy or biological response modifiers, do not accurately reflect the primary action of alkylating agents. For example, promoting apoptosis or altering metabolism could be effects seen with different therapeutic agents but are not the defining characteristics of alkylating agents.

Alkylating agents are a class of chemotherapy drugs that primarily act by damaging the DNA of cancer cells. Their mechanism involves the addition of alkyl groups to the DNA structure, which can lead to a variety of DNA lesions, including cross-links between DNA strands. This damage disrupts the normal process of DNA replication and transcription, ultimately preventing cancer cells from dividing and proliferating.

By interfering with these critical processes, alkylating agents induce cellular stress responses that may lead to cell cycle arrest or apoptosis. The targeted effect on the DNA directly ties into the agents' ability to halt the growth of tumors, making this mechanism a foundational aspect of their use in cancer treatment.

The other options, while they may represent different mechanisms associated with other types of chemotherapy or biological response modifiers, do not accurately reflect the primary action of alkylating agents. For example, promoting apoptosis or altering metabolism could be effects seen with different therapeutic agents but are not the defining characteristics of alkylating agents.